📌 Key Takeaways
- Topic: Top Fumed Silica Manufacturers: Global Leaders and Emerging Suppliers (2026)
- Keywords: Aerosil 200
- Published: 2026-11-20 05:15:07
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for 3D Printing: Uses in Resins, Powders and Binder Jetting
- Cab-O-Sil Alternative: Equivalent Fumed Silica Grades and Performance Comparison
- What Is Silicon Dioxide? Simple Definition, Formula and Everyday Examples
- Tan, A., Eskandar, N. G., Rao, S. & Prestidge, C. A. First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen. Drug Deliv. Transl. Res. 4, 212-221 (2014). Article CAS PubMed Google Scholar
- Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz
- Huo, M. et al. Upconversion nanoparticles hybridized cyanobacterial cells for near‐infrared mediated photosynthesis and improved photodynamic therapy. Adv. Funct. Mater. 31, 2010196 (2021). Post CAS Google Scholar
- Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained
Silica as a Thickening Agent: How It Works in Liquids, Resins and Gels
What is silica (SiO₂)?
toothpaste grade silica
What is the difference between fumed silica and precipitated silica?
green tire silica
What drives silica raw material prices?
Sibelco quartz The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.